Skip to main content
Equibles

CITADEL ADVISORS LLC

Position in RVMD — Revolution Medicines, Inc.

CIK 1423053 MIAMI, FL
Back to RVMD Full portfolio

Position in RVMD

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$38,905,153
-$64,827,900 QoQ
Shares Held
400,053
-69.3% QoQ
Ownership
0.188%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in RVMD Over Time

Shares Held

Position Value (USD)

Derivatives in RVMD

reported options exposure · as of Mar 31, 2026
CallValue
$26,734,025
CallShares
274,900
PutValue
$32,043,875
PutShares
329,500

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

CITADEL ADVISORS LLC holds $5,783,571,443 across 373 Biotechnology names. RVMD ranks #34 (0.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 INSM
INSMED Inc
 2,182,571 $356,894,009
2 ONC
BeOne Medicines Ltd.
 1,032,298 $306,561,536
3 BMRN
Biomarin Pharmaceutical Inc
 4,512,634 $254,918,694
4 JAZZ
Jazz Pharmaceuticals plc
 1,259,444 $238,097,887
5 MDGL
Madrigal Pharmaceuticals, Inc.
 453,843 $237,573,195
6 BBIO
BridgeBio Pharma, Inc.
 3,173,940 $235,696,783
7 TERN
Terns Pharmaceuticals, Inc.
 3,218,810 $169,695,662
8 PTGX
Protagonist Therapeutics, Inc
 1,551,900 $163,570,260

All Filings in RVMD

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $38,905,153 400,053
2026-03-31 $32,043,875 329,500
2026-03-31 $26,734,025 274,900
2025-12-31 $9,860,670 123,800
2025-12-31 $1,003,590 12,600
2025-12-31 $103,733,053 1,302,361
2025-09-30 $2,582,510 55,300
2025-09-30 $7,266,520 155,600
2025-09-30 $55,109,968 1,180,085
2025-06-30 $4,867,317 132,300
2025-06-30 $54,363,662 1,477,675
2025-06-30 $2,288,338 62,200
2025-03-31 $3,716,336 105,100
2025-03-31 $1,135,056 32,100
2025-03-31 $4,705,248 133,067
2024-12-31 $5,995,178 137,064
2024-12-31 $2,956,824 67,600
2024-12-31 $5,874,282 134,300
2024-09-30 $5,233,390 115,400
2024-09-30 $485,245 10,700
2024-09-30 $12,740,492 280,937
2024-06-30 $469,601 12,100
2024-06-30 $15,867,157 408,842
2024-06-30 $554,983 14,300
2024-03-31 $683,630 21,211
2024-03-31 $18,954,075 588,088
2024-03-31 $354,530 11,000
2023-12-31 $25,927,551 904,029
2023-12-31 $544,920 19,000
2023-12-31 $1,334,537 46,532
2023-09-30 $6,821,957 246,458
2023-09-30 $412,432 14,900
2023-09-30 $343,232 12,400
2023-06-30 $222,025 8,300
2023-06-30 $326,350 12,200
2023-03-31 $6,996 323
2023-03-31 $155,952 7,200
2023-03-31 $179,778 8,300
2022-12-31 $126,246 5,300
2022-12-31 $54,786 2,300
2022-12-31 $4,209,922 176,739
2022-09-30 $474,305 24,052
2022-09-30 $1,082,628 54,900
2022-06-30 $3,840,698 197,060
2022-03-31 $1,704,118 66,802
2021-12-31 $281,904 11,200
2021-12-31 $9,159,487 363,905
2021-12-31 $885,984 35,200
2021-09-30 $2,570,038 93,422
2021-09-30 $302,610 11,000

Report a Problem

Category
Description
Email (optional, for follow-up)